Sample Diluent Concentrate 2 (2X)

• Applications: ELISA

Sample Diluent Concentrate 2 (2X) Summary

• Source: N/A
• Inter-Assay: See PDF Datasheet for details
• Intra-Assay: See PDF Datasheet for details
• Spike Recovery: See PDF Datasheet for details
• Sample Volume: See PDF Datasheet for details

Applications/Dilutions

• Dilutions:
  • ELISA
• Application Notes: No significant interference observed with available related molecules.

Packaging, Storage & Formulations

• Storage: Store the unopened product at 2 - 8 °C. Do not use past expiration date.

Notes

This product is produced by and ships from R&D Systems, Inc., a Bio-Techne brand.

Alternate Names for Sample Diluent Concentrate 2 (2X)

• Buffers, Chelators and Reagents

Publications for Buffers, Chelators and Reagents (DYC002)(5)

Publications using DYC002

• Muraoka, H;Kazuno, H;Hashimoto, A;Sootome, H;Ohkubo, S; Pimitespib, an HSP90 Inhibitor, Enhances the Efficacy of PARP Inhibitors in PARP Inhibitor-Insensitive Breast Cancer Cells Cancer science 2025-04-01 [PMID: 40167031] (Western Blot, Human)
• Z Li, EA Korhonen, A Merlini, J Strauss, E Wihuri, H Nurmi, S Antila, J Paech, U Deutsch, B Engelhardt, S Chintharla, GY Koh, A Flügel, K Alitalo Angiopoietin-2 blockade ameliorates autoimmune neuroinflammation by inhibiting leukocyte recruitment into the CNS J. Clin. Invest., 2020-04-01;0(0):. 2020-04-01 [PMID: 32149735] (Mouse)
• H Irie, K Ito, Y Fujioka, K Oguchi, A Fujioka, A Hashimoto, H Ohsawa, K Tanaka, K Funabashi, H Araki, Y Kawai, T Shimamura, R Wadhwa, S Ohkubo, K Matsuo TAS0728, a covalent-binding, HER2-selective kinase inhibitor shows potent antitumor activity in preclinical models Mol. Cancer Ther., 2019-02-20;0(0):. 2019-02-20 [PMID: 30787176]
• M Chiba, H Imazu, M Kato, K Ikeda, H Arakawa, T Kato, K Sumiyama, S Homma Novel quantitative analysis of the S100P protein combined with endoscopic ultrasound-guided fine needle aspiration cytology in the diagnosis of pancreatic adenocarcinoma Oncol. Rep, 2017-02-21;0(0):. 2017-02-21 [PMID: 28260012] (Human)
• Hutchins BM, Kazane SA, Staflin K, Forsyth JS, Felding-Habermann B, Schultz PG, Smider VV Site-specific coupling and sterically controlled formation of multimeric antibody fab fragments with unnatural amino acids. J. Mol. Biol., 2011-01-13;406(4):595-603. 2011-01-13 [PMID: 21237172] (Human)